BSE Live
Oct 24, 16:01Prev. Close
507.45
Open Price
507.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 24, 15:56Prev. Close
507.75
Open Price
507.75
Bid Price (Qty.)
493.95 (54)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Aarti Drugs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 2,158.80 | 2,253.74 | 2,488.71 | 2,251.17 | 1,914.89 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 2,158.80 | 2,253.74 | 2,488.71 | 2,251.17 | 1,914.89 | |
| Total Operating Revenues | 2,173.65 | 2,266.91 | 2,497.97 | 2,251.17 | 1,914.89 | |
| Other Income | 13.57 | 4.18 | 2.23 | 4.77 | 6.42 | |
| Total Revenue | 2,187.23 | 2,271.09 | 2,500.20 | 2,255.95 | 1,921.31 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 1,332.29 | 1,466.57 | 1,702.44 | 1,524.56 | 1,127.79 | |
| Purchase Of Stock-In Trade | 44.34 | 35.86 | 47.01 | 58.31 | 43.17 | |
| Operating And Direct Expenses | 352.32 | 326.86 | 319.57 | 282.81 | 222.37 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 22.00 | 26.77 | -6.72 | -77.94 | -9.08 | |
| Employee Benefit Expenses | 85.25 | 80.98 | 74.99 | 69.32 | 69.29 | |
| Finance Costs | 29.68 | 30.16 | 32.53 | 20.07 | 22.61 | |
| Depreciation And Amortisation Expenses | 47.79 | 47.67 | 47.29 | 47.39 | 47.60 | |
| Other Expenses | 74.80 | 63.74 | 78.27 | 75.94 | 60.09 | |
| Total Expenses | 1,988.47 | 2,078.61 | 2,295.39 | 2,000.45 | 1,583.83 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 198.75 | 192.48 | 204.81 | 255.50 | 337.49 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | |
| Profit/Loss Before Tax | 198.75 | 192.48 | 204.81 | 255.50 | 337.71 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 48.25 | 49.60 | 53.25 | 65.50 | 84.50 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 3.50 | 1.00 | -1.25 | -5.00 | -4.50 | |
| Tax For Earlier Years | -10.31 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 41.44 | 50.60 | 52.00 | 60.50 | 80.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 157.31 | 141.88 | 152.81 | 195.00 | 257.71 | |
| Profit/Loss From Continuing Operations | 157.31 | 141.88 | 152.81 | 195.00 | 257.71 | |
| Profit/Loss For The Period | 157.31 | 141.88 | 152.81 | 195.00 | 257.71 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 17.18 | 15.35 | 16.50 | 21.04 | 27.65 | |
| Diluted EPS (Rs.) | 17.18 | 15.35 | 16.50 | 21.04 | 27.65 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 773.01 | 893.45 | 989.58 | 886.71 | 692.29 | |
| Indigenous Raw Materials | 535.15 | 523.30 | 660.57 | 589.17 | 395.72 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 33.33 | 34.85 | 33.12 | 24.37 | 18.96 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 9.13 | 9.19 | 9.26 | 9.26 | 23.30 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 10.00 | 10.00 | 10.00 | 10.00 | 25.00 |
21.07.2025
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y
07.05.2025